Position in BMY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$463,552
+$17,593 QoQ
Shares Held
8,045
+9.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#1,588
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STEPH & CO holds $2,307,781 across 8 Drug Manufacturers - General names. BMY ranks #3 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,734 | $948,323 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
3,799 | $479,965 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
8,045 | $463,552 | |
| 4 | ABBV |
AbbVie Inc.
|
1,250 | $314,550 | |
| 5 | PFE |
Pfizer Inc
|
1,695 | $40,815 | |
| 6 | GSK |
GSK plc
|
527 | $27,625 | |
| 7 | BIIB |
Biogen Inc.
|
97 | $20,957 | |
| 8 | LLY |
ELI LILLY & Co
|
10 | $11,994 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $463,552 | 8,045 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $445,959 | 7,353 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $389,177 | 7,215 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $229,694 | 5,093 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $491,970 | 10,628 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $655,459 | 10,747 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $638,901 | 11,296 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $608,100 | 11,753 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $477,221 | 11,491 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $621,313 | 11,457 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $440,137 | 8,578 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $647,087 | 11,149 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $692,386 | 10,827 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $749,033 | 10,807 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $777,275 | 10,803 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $722,985 | 10,170 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $755,832 | 9,816 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $593,879 | 8,132 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $500,171 | 8,022 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $476,969 | 8,061 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $489,523 | 7,326 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $362,681 | 5,745 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $360,332 | 5,809 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $261,899 | 4,344 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $337,747 | 5,744 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $320,170 | 5,744 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||